Thioredoxin reductase and cancer cell growth inhibition by organotellurium compounds that could be selectively incorporated into tumor cells
- 14 October 2003
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 11 (23), 5091-5100
- https://doi.org/10.1016/j.bmc.2003.08.021
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The role of the redox protein thioredoxin in cell growth and cancerFree Radical Biology & Medicine, 2000
- Thioredoxin, a putative oncogene product,is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survivalHuman Pathology, 2000
- Thioredoxin reductaseBiochemical Journal, 2000
- Thioredoxin-dependent Redox Regulation of p53-mediated p21 ActivationPublished by Elsevier BV ,1999
- Phage display identifies thioredoxin and superoxide dismutase as novel protein kinase C-interacting proteins: thioredoxin inhibits protein kinase C-mediated phosphorylation of histoneBiochemical Journal, 1999
- Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1The EMBO Journal, 1998
- AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1Proceedings of the National Academy of Sciences of the United States of America, 1997
- Cloning and Expression of a Novel Mammalian ThioredoxinJournal of Biological Chemistry, 1997
- The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF): Thioredoxin mRNA is elevated in some human tumorsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1994
- Coexpression of adult T-cell leukemia-derived factor, a human thioredoxin homologue, and human papillomavirus DNA in neoplastic cervical squamous epitheliumCancer, 1991